GAD THOMAS (President and Chairman) sold 36.1% of their position (150K shares) of Y-MABS THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.00M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 12/15/2023ACC: 0001104659-23-126508
DirectorOfficer· President and Chairman
Since Sep 2018
-150K
Net shares
Net seller
$1.00M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
150K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−50K
Price / share
$6.58
Trade value
$329K
% of position
12.0%
12/13/2023
415.03K→365.03K
Common Stock
Indirect
Shares
−50K
Price / share
$6.83
Trade value
$341.50K
% of position
13.7%
12/14/2023
365.03K→315.03K
Common Stock
Indirect
Shares
−50K
Price / share
$6.61
Trade value
$330.50K
% of position
15.9%
12/15/2023
315.03K→265.03K
Total
Net shares
−150K
Net value
-$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/13/2023 | S · Sale | −50K | $6.58 | $329K | 12.0% | 415.03K | 365.03K |
| Common Stock Indirect | 12/14/2023 | S · Sale | −50K | $6.83 | $341.50K | 13.7% | 365.03K | 315.03K |
| Common Stock Indirect | 12/15/2023 | S · Sale | −50K | $6.61 | $330.50K | 15.9% | 315.03K | 265.03K |
| Total | −150K | -$1M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned60K
Common Stock
DirectShares owned90.50K
Total
90.50K direct·60K indirect150.50K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 60K | Indirect |
| Common Stock | 90.50K | Direct |
| Total | 150.50K | 90.50K direct·60K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported